Cano Health Highlights Long-Term Value Creation Strategy in New Investor Presentation

Draws a sharp contrast between the Board and management’s clear long-term stockholder value creation plan and the former directors’ short-term, self-interested agenda Urges stockholders to vote on the WHITE proxy card “FOR” re-election of the Company’s directors and the proposed reverse stock split MIAMI, May 31, 2023 /PRNewswire/ — Cano Health, Inc. (“Cano Health” or … Read more

Veeva Announces Fiscal 2024 First Quarter Results

Total Revenues of $526.3M, up 4% Year Over Year;Subscription Services Revenues of $414.5M, up 3% Year Over Year PLEASANTON, Calif., May 31, 2023 /PRNewswire/ — Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended April 30, 2023. “It was … Read more

Highlights of Consumable Suppliers and their Sustainability Initiatives

DUBLIN, May 31, 2023 /PRNewswire/ — The “2022 Perceptions of Environmental Sustainability in the Life Sciences” report has been added to  ResearchAndMarkets.com’s offering. This study highlights the perceptions of life science consumable suppliers and their sustainability initiatives. This report addresses the barriers to achieving environmental sustainability from the consumer perspective, including the reasons sustainable solutions are … Read more

Increasing Awareness and Diagnosis of PAH Bolsters Growth

DUBLIN, May 31, 2023 /PRNewswire/ — The “Global Pulmonary Arterial Hypertension Market: Analysis By Drug Class, By Type, By Route of Administration, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028” report has been added to  ResearchAndMarkets.com’s offering. The global pulmonary arterial hypertension market was valued at US$8.18 … Read more

Redwood Pharma presents positive results from a clinical study with RP501 against dry eye

STOCKHOLM, May 31, 2023 /PRNewswire/ — Redwood Pharma AB (publ) announces positive results from the company’s clinical study with RP501, a medical technology self-care product being developed for the treatment of dry eye. The results show that RP501 is safe and well-tolerated and that the product produces statistically significant positive results on several subjective efficacy measures, … Read more

Fusion Pharmaceuticals to Present at the Jefferies Healthcare Conference

HAMILTON, ON and BOSTON, May 31, 2023 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will present in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 7, 2023 at 04:00 p.m. ET. Presenting on behalf of … Read more

ASICS REACHES NEW LEVELS OF COMFORT FOR A STABILITY SHOE WITH THE LANDMARK GEL-KAYANO™ 30

Latest iteration of the iconic GEL-KAYANO™ series combines market-leading stability with unprecedented levels of comfort. This is achieved through new 4D GUIDANCE SYSTEM™ technology that provides adaptive stability for the runner by adjusting to pronation changes throughout the run. The new GEL-KAYANO™ 30 running shoe will be available instore and online globally from June 2023. … Read more

JenCare Senior Medical Center Hosts Hundreds for National Senior Health and Fitness Day at Lafreniere Park

Announces year-end goal of certifying more than 2,500 at-risk seniors for monthly food boxes provided through USDA’s Commodity Supplemental Food Program NEW ORLEANS, May 31, 2023 /PRNewswire/ — Hundreds of seniors participated in a wide range of health and fitness-focused activities today, as part of JenCare’s second annual Super Senior Fest at Lafreniere Park in … Read more

LE LABORATOIRE DR. WISPLINGHOFF ET LABCONNECT ANNONCENT UNE ALLIANCE STRATÉGIQUE POUR ÉLARGIR LES SERVICES DE LABORATOIRE CENTRAL A L’ÉCHELLE MONDIALE AFIN D’ACCÉLÉRER LA MISE AU POINT DE MÉDICAMENTS USA – Français USA – Deutsch USA – English USA – English USA – español Middle East – Arabic

JOHNSON CITY, Tennessee et COLOGNE, Allemagne, 31 mai 2023 /PRNewswire/ — Le laboratoire Dr. Wisplinghoff et LabConnect ont annoncé aujourd’hui le début de leur alliance stratégique visant à fournir des services de laboratoire central de haute qualité et sur mesure en Europe afin de soutenir les essais cliniques dans le monde entier. Le laboratoire Dr. Wisplinghoff, situé à … Read more